MarketSynthon (company)
Company Profile

Synthon (company)

Synthon is a Dutch multinational that produces generic human drugs.

History
In 2007 the company started developing biopharmaceuticals. In May 2012 Synthon announced that it bought the Biolex LEX System for manufacturing biopharmaceuticals in Lemna. The sale also included two preclinical biologics made with the LEX System, BLX-301, a humanized and glyco-optimized anti-CD20 antibody for non-Hodgkin's B-cell lymphoma and other B-cell malignancies and BLX-155, a direct-acting thrombolytic. The financial terms of the sale were not disclosed. == See also ==
tickerdossier.comtickerdossier.substack.com